KRRO · Korro Bio Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 8.88 USD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 4 / 13 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 27 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +36.7% |
| Sales growth Q/Q | +18.5% |
| Distance from 52-week high | +82.7% |
| Market cap (USD) | $196.1M |